NPS+ Melanoma (US) 2017
本報告依據美國的100名腫瘤專門醫生、皮膚腫瘤專門醫生的調查結果，提供黑色素瘤治療藥的8個領導品牌產品的醫生的使用趨勢和各種見解的比較、分析，支援測量客戶忠誠度的NPS (淨推薦值) 指標的改善。
Lack of experience may be keeping two melanoma treatments from earning higher satisfactions scores. Results of our survey show that US-based medical oncologists and dermato-oncologists are optimistic about these two drugs, but haven't had many opportunities to prescribe them. Meanwhile, the top 2 brands are comfortably ahead thanks mainly to widespread perceptions about their clinical effectiveness and benefit to patients.
Find out how doctors rate your brand, get insight into why, and learn what you can do to boost your satisfaction score in FirstView's NPS+ Melanoma 2017 (US) .
Building on the respected net promoter score (NPS), the report compares eight major melanoma drugs with easy-to-use KPIs that highlight ways you can improve brand health. You'll also see how loyal doctors are to your brand, learn which promotional messages resonate best, and get doctors' candid thoughts in a unique "Brand DNA" section.
We surveyed 100 US-based medical oncologists and dermato-oncologists chosen from the largest community of validated physicians in the world. The same community that pharma market researchers trust for reliable, fast intelligence.
We conducted the survey between May 3rd and 9th, 2017.
NPS+ Melanoma 2017 (US) explores key issues affecting brand loyalty for drug manufacturers. You'll learn:
NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.
NPS measures overall brand satisfaction and loyalty by asking one simple question:
"How likely are you to recommend this brand to a colleague?"
Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)-are used to classify respondents into 3 categories:
The percentage of detractors - the percentage of promoters = NPS.
For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.
NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.
NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty.
Each NPS+ report examines doctors' relationships with the brands used to treat a major disease area-measuring brand loyalty and showing you how it affects your market share. NPS+ also examines "brand DNA", revealing in doctors' own words what brands mean to them.
Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next.